Search

Your search keyword '"HER2 Positive Breast Cancer"' showing total 2 results
Start Over Descriptor "HER2 Positive Breast Cancer" Language japanese
2 results on '"HER2 Positive Breast Cancer"'

1. ペルツズマブ（遺伝子組換え）・トラスツズマブ （遺伝子組換え）・ボルヒアルロニダーゼ アルファ （遺伝子組換え）（フェスゴ®配合皮下注 MA，同 IN） の薬理学的特性及び臨床開発の経緯.

Author

榮田 まり子, 小谷 直生, 米屋 孝明, 鄭 悦, and 羽原 裕二

Subjects
CANCER chemotherapy, MEDICAL personnel, HER2 positive breast cancer, SUBCUTANEOUS injections, INTRAVENOUS therapy, TRASTUZUMAB
Abstract

Copyright of Folia Pharmacologica Japonica is the property of Japanese Pharmacological Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2024
Full Text
View/download PDF

2. Tolerability and efficacy of a chemotherapy regimen avoiding Anthracycline for HER 2 positive elderly and poor risked breast cancer patients

Subjects
Elderly patients, pCR rate, Neo-adjuvant chemotherapy, RDI, HER２ positive breast cancer
Abstract

Tolerability and efficacy of chemotherapy avoiding anthracycline regimen were examined histologically in ER negative and HER２positive elderly and poor risked breast cancer patients because of serious toxicity of Anthracycline regimen. Neo-adjuvant chemotherapy with ４ to ６ courses of Paclitaxel with Trastuzumab was given to ６ patients, Pertuzumab was added in 2 cases to obtain complete response. Adverse events were controllable, the primary treatment was completed without reducing the dose of drugs（RDI was １００％）. Clinical CR rate was recognized in all ６ patients and pathological CR was proved in all of the operated５cases.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results